- Home
- IQV vs STLA Comparison
IQV vs STLA Comparison
Compare IQV & STLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQV
- STLA
- Stock Information
- Founded
- IQV 1982
- STLA 2021
- Country
- IQV United States
- STLA Netherlands
- Employees
- IQV N/A
- STLA N/A
- Industry
- IQV Biotechnology: Commercial Physical & Biological Resarch
- STLA Auto Manufacturing
- Sector
- IQV Health Care
- STLA Consumer Discretionary
- Exchange
- IQV Nasdaq
- STLA Nasdaq
- Market Cap
- IQV 31.6B
- STLA 27.0B
- IPO Year
- IQV 2013
- STLA N/A
- Fundamental
- Price
- IQV $150.19
- STLA $9.42
- Analyst Decision
- IQV Buy
- STLA Hold
- Analyst Count
- IQV 20
- STLA 8
- Target Price
- IQV $236.75
- STLA $17.65
- AVG Volume (30 Days)
- IQV 2.4M
- STLA 24.6M
- Earning Date
- IQV 05-06-2025
- STLA 02-26-2025
- Dividend Yield
- IQV N/A
- STLA 8.31%
- EPS Growth
- IQV 2.74
- STLA N/A
- EPS
- IQV 7.49
- STLA 1.90
- Revenue
- IQV $15,405,000,000.00
- STLA $162,416,399,263.00
- Revenue This Year
- IQV $4.08
- STLA $6.82
- Revenue Next Year
- IQV $5.88
- STLA $4.78
- P/E Ratio
- IQV $20.03
- STLA $4.94
- Revenue Growth
- IQV 2.81
- STLA N/A
- 52 Week Low
- IQV $135.97
- STLA $8.39
- 52 Week High
- IQV $252.88
- STLA $25.05
- Technical
- Relative Strength Index (RSI)
- IQV 40.77
- STLA 41.75
- Support Level
- IQV $137.49
- STLA $8.89
- Resistance Level
- IQV $154.17
- STLA $9.57
- Average True Range (ATR)
- IQV 8.48
- STLA 0.53
- MACD
- IQV 1.00
- STLA 0.09
- Stochastic Oscillator
- IQV 58.37
- STLA 58.91
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About STLA Stellantis N.V.
Stellantis was created out of the merger of US-based Fiat Chrysler Automobiles, or FCA, and French-based Peugeot, or PSA, in January 2021, resulting in the fourth-largest automotive original equipment manufacturer, or OEM, by vehicle sales. In 2023 it sold 6.4 million vehicles, 44% and 30% in Europe and North America, respectively. North America is the most profitable region, contributing 53% of operating income. Its brands include Fiat, Jeep, Chrysler, Ram, Peugeot, Citroen, Opel, Alfa Romeo, and Maserati.